B
BehaVR
Translates proven science into immersive and engaging XR therapeutics for mental and behavioral health
About BehaVR
BehaVR is a company that leverages the therapeutic powers of Virtual Reality (VR) to provide scalable and effective mental health treatments. The company operates in the healthcare market, focusing on reducing stress, anxiety, and opioid use disorder through innovative VR experiences. BehaVR serves a diverse range of clients including individual patients, healthcare providers, employers, and members of health plans. The business model revolves around offering VR-based therapeutic programs that can be accessed by patients and healthcare providers, either directly or through partnerships with healthcare institutions. Revenue is generated through the sale and licensing of these VR programs, as well as through collaborations with healthcare organizations and research institutions. BehaVR's solutions are designed to be accessible to a wide audience, making high-quality mental health support more convenient and effective. The company's notable collaborations include partnerships with Johns Hopkins HealthCare and NIH-funded projects aimed at expanding the reach of their innovative treatments.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2016
- Headquarters
- Louisville, United States
- Employees
- 52
- Open positions
- None listed
- Dealroom signal
- 86.0/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Mental Health, Immersive Technologies, Digital Therapeutics, Tech for Biotech and Pharma, Tech for Patients, DT and LS, science-based
- Technology
- Deep Tech, Virtual Reality
- Business model
- SaaS
- Client focus
- b2c
- Investment activity
- 2 companies, latest Nov 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Feb 2025 | $0 | — | XRHealth | ↗ |
| MERGER✓Other financing | Nov 2023 | $0 | — | Fern Health | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for BehaVR is 890 monthly website visits, up 0% over the last three months. BehaVR's team grew 57.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Fern HealthNew York City, United StatesFern Health - Digital Programs for Musculoskeletal Pain
→
Oxford VRAustin, United StatesTransforming mental health for millions with state-of-the-art immersive technology
$50Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Mammoth View (KSTC)
Arkitekt Ventures
City Light Capital
Series A6 investors entered at this stage
Oxford Science Enterprises
Optum Ventures
Chrysalix Venture Capital
Accenture- TCThornton Capital
Confluent Health
Other known investors7 additional known investors
- Fern Health
XRHealth
Accenture Ventures
Enke Bashllari
Keyhorse Capital (KSTC)
Pavan Choksi
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about BehaVR on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BehaVR’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.